GITNUX MARKETDATA REPORT 2024

Humalog Duration Statistics

The mean duration of action for Humalog insulin is approximately 4 to 5 hours, with a range of 3 to 6 hours.

In this post, we will explore key statistics related to the duration and effectiveness of Humalog, a rapid-acting insulin widely used in the management of both Type 1 and Type 2 diabetes. From its peak action time to duration of effect, as well as insights into side effects and administration methods, we will delve into the data that underpins the use and impact of Humalog in diabetes care.

Statistic 1

"In clinical trials, Humalog reduced HbA1c levels by about 0.4% more than regular insulin."

Sources Icon

Statistic 2

"The peak action of Humalog usually occurs between 1 to 2 hours after administration."

Sources Icon

Statistic 3

"Humalog is typically administered subcutaneously 15 minutes before a meal."

Sources Icon

Statistic 4

"Humalog is effective in both Type 1 and Type 2 diabetes management."

Sources Icon

Statistic 5

"It is found that people with type 1 diabetes using Humalog required fewer insulin doses."

Sources Icon

Statistic 6

"The bioavailability of Humalog is similar to that of regular human insulin."

Sources Icon

Statistic 7

"Humalog's formulation allows it to be administered shortly before or even immediately after a meal."

Sources Icon

Statistic 8

"Humalog's rapid onset can significantly assist in managing postprandial blood glucose levels."

Sources Icon

Statistic 9

"Humalog can also be used in continuous subcutaneous insulin infusion pumps."

Sources Icon

Statistic 10

"Humalog generally has a duration of action of about 3 to 5 hours."

Sources Icon

Statistic 11

"The half-life of Humalog is approximately 1 hour."

Sources Icon

Statistic 12

"Humalog Mix75/25 has a longer duration of action lasting up to 24 hours."

Sources Icon

Statistic 13

"Weight gain is noted in approximately 17% of patients using Humalog."

Sources Icon

Statistic 14

"Approximately 58% of Humalog users experience hypoglycemia as a side effect."

Sources Icon

Statistic 15

"Clinical studies show Humalog is more effective when compared to regular insulin in reducing post-meal glucose spikes."

Sources Icon

Statistic 16

"Humalog has been on the market since 1996."

Sources Icon

Statistic 17

"Insulin lispro protamine in Humalog Mix50/50 prolongs insulin release."

Sources Icon

Statistic 18

"The onset of action for Humalog (insulin lispro) is typically within 15 minutes."

Sources Icon

Statistic 19

"Humalog Mix50/50 combines 50% insulin lispro protamine and 50% insulin lispro."

Sources Icon

Statistic 20

"Humalog can be mixed with NPH insulin but not any other insulin formulations."

Sources Icon
In conclusion, Humalog has proven to be a valuable option for managing both Type 1 and Type 2 diabetes due to its rapid onset, shorter duration of action, and effectiveness in reducing postprandial glucose spikes. With its ability to be administered shortly before or after a meal and its compatibility with insulin pumps, Humalog offers flexibility and convenience for patients. However, potential side effects such as weight gain and hypoglycemia should be carefully monitored. Overall, the statistics highlight Humalog’s significant impact on glycemic control and its role as a key player in diabetes management since its introduction to the market in 1996.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!